Polymers News and Research

RSS

The potential efficacy of nasal nanoparticle COVID-19 vaccines

The current paper reviews progress in this field regarding nasal nanoparticle vaccines for COVID-19.

30 Mar 2022

Smart textile arm sleeve will be an effective and easy-to-use treatment for lymphedema patients

A ‘breakthrough’ smart textile arm sleeve will use electrical stimulation to reduce swelling and discomfort for patients with lymphedema.

30 Mar 2022

NTU-developed coating for probiotics ensures effective delivery of beneficial bacteria into the intestine

Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed probiotics with a unique edible coating that ensures the beneficial bacteria successfully reach the intestine once they are ingested.

25 Mar 2022

Impact of polystyrene microplastic particles on freshwater organisms

...

23 Mar 2022

Using CRISPR/Cas to develop biosafety materials

Researchers discuss the use of the highly efficient CRISPR/Cas technologies to identify viral genome sequences for biosafety purposes.

21 Mar 2022

SEQENS makes multi-million-dollar investment in U.S. R&D laboratory

SEQENS, an integrated leader in the manufacturing of active ingredients and pharmaceutical intermediates, announced a multi-million-dollar investment in its research and development laboratory located in Devens, Mass.

From SEQENS 21 Mar 2022

Researchers find unusual way of stabilizing cancer-suppressing protein

The p53 protein protects our cells from cancer and is an interesting target for cancer treatments. The problem is, however, that it breaks down rapidly in the cell. Researchers at Karolinska Institutet in Sweden have now found an unusual way of stabilizing the protein and making it more potent.

14 Mar 2022

Efficient inactivation of SARS-CoV-2 on N95 masks by an antimicrobial coating

In a recent study, researchers demonstrate that Goldshield75 coating inactivated SARS-CoV-2 on N95 filters and masks.

14 Mar 2022

Assessment of oligonucleotides as COVID-19 treatment

A recent study posted to the bioRxiv* pre-print server assessed the ability of oligonucleotides in preventing the development of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virions.

8 Mar 2022

Durable selenium nanoparticle fabrics with antiviral and antibacterial properties

Researchers graft SeNPs on polyester fabric through a flat screen-printing technique and observed their antimicrobial activity.

8 Mar 2022

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

Mercia Asset Management, Calculus Capital, Downing Ventures and BGF scale joint investment in latest fundraise.

From MIP Discovery 1 Mar 2022

Application of various nanoparticle-capsulated siRNA as therapeutics for SARS-CoV-2 infection

In a review published in the International Journal of Molecular Sciences, researchers have been reviewing the use of siRNAs to target coronaviruses.

25 Feb 2022

Researchers show how the biological system can be steered with artificial organic neurons

For the first time, researchers demonstrate an artificial organic neuron, a nerve cell, that can be integrated with a living plant and an artificial organic synapse.

23 Feb 2022

Innovative coating kills SARS-CoV-2 and E. coli

Researchers develop a low-cost, non-toxic, and scalable antimicrobial polymer that can be functionalized on diverse fabrics.

16 Feb 2022

Assessing potential allergic reactions in COVID-19 vaccinated patients

Researchers analyze suspected reactions in patients vaccinated with the first and/or second dose of SARS-CoV-2 vaccines.

13 Feb 2022

Process-scale Chromatography Bed Supports

Porvair Sciences high performance, precision manufactured Vyon® porous plastics are perfect support materials for chromatographic resins used in the isolation and purification steps of pharmaceutical drug and vaccine production.

From Porvair Sciences Limited 9 Feb 2022

New approach to make RNA vaccines easier to swallow

Like most vaccines, RNA vaccines have to be injected, which can be an obstacle for people who fear needles. Now, a team of MIT researchers has developed a way to deliver RNA in a capsule that can be swallowed, which they hope could help make people more receptive to them.

31 Jan 2022